118 related articles for article (PubMed ID: 35063277)
1. Impact of care by gynecologic oncologists on primary ovarian cancer survival: A population-based study.
Bouchard-Fortier G; Gien LT; Sutradhar R; Chan WC; Krzyzanowska MK; Liu SL; Ferguson SE
Gynecol Oncol; 2022 Mar; 164(3):522-528. PubMed ID: 35063277
[TBL] [Abstract][Full Text] [Related]
2. Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario.
Liu SL; Chan WC; Bouchard-Fortier G; Lheureux S; Ferguson SE; Krzyzanowska MK
Curr Oncol; 2022 Aug; 29(8):5988-6009. PubMed ID: 36005210
[TBL] [Abstract][Full Text] [Related]
3. Potential Strategies to Increase Gynecologic Oncologist Treatment for Ovarian Cancer.
Stewart SL; Mezzo JL; Nielsen D; Rim SH; Moore AR; Bhalakia A; House M
J Womens Health (Larchmt); 2021 Jun; 30(6):769-781. PubMed ID: 34128688
[TBL] [Abstract][Full Text] [Related]
4. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
5. The impact of expanding gynecologic oncology care to ovarian cancer patients in small cities and rural communities.
Swayze EJ; Strzyzewski L; Avula P; Zebolsky AL; Hoekstra AV
Gynecol Oncol; 2021 Jun; 161(3):852-857. PubMed ID: 33888339
[TBL] [Abstract][Full Text] [Related]
6. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
[TBL] [Abstract][Full Text] [Related]
8. Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.
Rim SH; Hirsch S; Thomas CC; Brewster WR; Cooney D; Thompson TD; Stewart SL
World J Obstet Gynecol; 2016; 5(2):187-196. PubMed ID: 29520338
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of neoadjuvant chemotherapy versus primary debulking surgery in patients with ovarian cancer: a meta-analysis.
Lv X; Cui S; Zhang X; Ren C
J Gynecol Oncol; 2020 Mar; 31(2):e12. PubMed ID: 31912670
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
So KA; Hong JH; Jin HM; Kim JW; Song JY; Lee JK; Lee NW
Gynecol Oncol; 2014 Mar; 132(3):551-5. PubMed ID: 24440470
[TBL] [Abstract][Full Text] [Related]
11. Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.
Warren JL; Harlan LC; Trimble EL; Stevens J; Grimes M; Cronin KA
Gynecol Oncol; 2017 Jun; 145(3):486-492. PubMed ID: 28372872
[TBL] [Abstract][Full Text] [Related]
12. Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
Garcia-Soto AE; Java JJ; Nieves Neira W; Pearson JM; Cohn DE; Lele SB; Tewari KS; Walker JL; Alvarez Secord A; Armstrong DK; Copeland LJ
Gynecol Oncol; 2016 Dec; 143(3):484-489. PubMed ID: 27726923
[TBL] [Abstract][Full Text] [Related]
13. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
[TBL] [Abstract][Full Text] [Related]
14. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.
Matsuo K; Huang Y; Zivanovic O; Shimada M; Machida H; Grubbs BH; Roman LD; Wright JD
Gynecol Oncol; 2019 Sep; 154(3):505-515. PubMed ID: 31279493
[TBL] [Abstract][Full Text] [Related]
16. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
17. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials.
Chan JK; Java JJ; Fuh K; Monk BJ; Kapp DS; Herzog T; Bell J; Young R
Gynecol Oncol; 2016 Dec; 143(3):490-495. PubMed ID: 27771168
[TBL] [Abstract][Full Text] [Related]
18. An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.
Mandato VD; Torricelli F; Uccella S; Pirillo D; Ciarlini G; Ruffo G; Annunziata G; Manzotti G; Pignata S; Aguzzoli L
J Cancer; 2021; 12(15):4443-4454. PubMed ID: 34149908
[No Abstract] [Full Text] [Related]
19. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer.
Lawrie TA; Rabbie R; Thoma C; Morrison J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD010482. PubMed ID: 24142521
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma.
Hsieh SF; Lau HY; Wu HH; Hsu HC; Twu NF; Cheng WF
Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30795566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]